Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-1596
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis ; volume:16 ; number:1 ; day:22 ; month:3 ; year:2021 ; pages:1-15 ; date:12.2021
Diagnostic pathology ; 16, Heft 1 (22.3.2021), 1-15, 12.2021
- Creator
-
Fattahi, Fahimeh
Saeednejad Zanjani, Leili
Vafaei, Somayeh
Habibi Shams, Zohreh
Kiani, Jafar
Naseri, Marzieh
Gheytanchi, Elmira
Madjd, Zahra
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13000-021-01088-1
- URN
-
urn:nbn:de:101:1-2021050719573406195181
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fattahi, Fahimeh
- Saeednejad Zanjani, Leili
- Vafaei, Somayeh
- Habibi Shams, Zohreh
- Kiani, Jafar
- Naseri, Marzieh
- Gheytanchi, Elmira
- Madjd, Zahra
- SpringerLink (Online service)
Other Objects (12)
Phytoestrogens and colorectal cancer prognosis
Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer
Altered pathways and colorectal cancer prognosis
LRIG1 expression and colorectal cancer prognosis
Clinical features and prognosis of cardiac metastatic tumors
CCR5 status and metastatic progression in colorectal cancer
Cell competition in primary and metastatic colorectal cancer
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients
Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer
High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival
Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
Phytoestrogens and colorectal cancer prognosis
Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer
Altered pathways and colorectal cancer prognosis
LRIG1 expression and colorectal cancer prognosis
Clinical features and prognosis of cardiac metastatic tumors
CCR5 status and metastatic progression in colorectal cancer
Cell competition in primary and metastatic colorectal cancer
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients
Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer
High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival
Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
Phytoestrogens and colorectal cancer prognosis
Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer
Altered pathways and colorectal cancer prognosis
LRIG1 expression and colorectal cancer prognosis
Clinical features and prognosis of cardiac metastatic tumors
CCR5 status and metastatic progression in colorectal cancer
Cell competition in primary and metastatic colorectal cancer
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients
Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer
High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival